VEGFA was downregulated (fold regulation of −3.2345) in 71.9% (23/32) of cases in the present study, although this did not reach statistical significance.
← all excerpts
Identification of the possible therapeutic targets in the insulin-like growth factor 1 receptor pathway in a cohort of Egyptian hepatocellular carcinoma complicating chronic hepatitis C type 4.
1
—
—